# A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.

> **NCT00580229** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of South Florida** · enrollment: 50 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00580229
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580229, "A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00580229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*